The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Western District of Pennsylvania on behalf of investors who purchased Mylan N.V. (NASDAQ: MYL) securities between February 16, 2016 and May 7, 2019.
According to the Mylan lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: 1) the Food and Drug Administration’s investigation into the Company’s manufacturing plant in Morgantown, West Virginia was the result of whistleblower allegations, and not, as Mylan insinuated, the result of a “regular” inspection; and 2) defendants knew, or were reckless in not knowing that, as a result of Mylan’s continued efforts to remain uncooperative with the Food and Drug Administration, the Morgantown plant would continue to incur substantial setbacks.
If you suffered a loss in Mylan you have until August 25, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
To receive more information, please fill out the form.